PT - JOURNAL ARTICLE AU - ANNE-MARIE TOBIN AU - DOUGLAS J. VEALE AU - OLIVER FITZGERALD AU - SARAH ROGERS AU - PAUL COLLINS AU - DONAL O’SHEA AU - BRIAN KIRBY TI - Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis AID - 10.3899/jrheum.090822 DP - 2010 Jul 01 TA - The Journal of Rheumatology PG - 1386--1394 VI - 37 IP - 7 4099 - http://www.jrheum.org/content/37/7/1386.short 4100 - http://www.jrheum.org/content/37/7/1386.full SO - J Rheumatol2010 Jul 01; 37 AB - Objective. Patients with psoriasis and psoriatic arthritis (PsA) have an increased incidence of cardiovascular disease (CVD) and cardiovascular risk factors such as smoking, hypertension, and metabolic syndrome compared to the normal population. Patients with psoriasis and PsA may also have increased risk from nonconventional risk factors such as raised levels of homocysteine and excessive alcohol consumption. We conducted a comprehensive review of the literature on CVD and all cardiovascular risk factors in patients with psoriasis and PsA. Methods. Data sources: All studies identified from a Medline (www.ncbi.nlm.nih.gov) search pertaining to CVD, individual risk factors in psoriasis, and PsA were included. Study selection: Studies included a healthy reference population, were published between 1975 and 2009, and were written in English. Results. Our search yielded 14 studies that documented rates of CVD in patients with psoriasis and PsA compared to controls. Substantial evidence points to elevated risk of CVD in patients with psoriasis and PsA. Conclusion. It remains difficult to conclude if risk factors are caused by psoriasis or share a common pathogenesis. Physicians treating patients with psoriasis and PsA must be aware of all potential cardiovascular risk factors in their patients.